| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cca165d58f27686da488f4d61fcde5fb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-3478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00358 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-00234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0144
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0067 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-128 |
| filingDate |
2018-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1a934b02f6cfccf7bbcff0fb61298fa |
| publicationDate |
2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019055154-A2 |
| titleOfInvention |
SYSTEMS AND METHODS FOR THE TRANSSEPTIVE DELIVERY OF HEART THERAPEUTIC DEVICES |
| abstract |
A system and method used for placement of a heart therapeutic device (TDH) at a site within the heart, such as a site at the aortic valve. A cable is introduced percutaneously into the vascular system of a patient and positioned to pass from a femoral vein, through the heart via a transseptal puncture, and to a femoral artery. The venous end of the cable is then removed from the upper venous vasculature to the heart, and a TDH is attached to the cable. The TDH is pushed in a distal direction while the arterial end of the cable is pulled in the proximal direction to advance the TDH to the target site. A left ventricle redirector helps guide TDH and prevent cable migration to delicate heart structures during TDH progression. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11678988-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364377-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10888644-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065438-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11147673-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10959713-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020163829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000637-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11129603-B2 |
| priorityDate |
2017-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |